miR-19b Serves as a Prognostic Biomarker of Breast Cancer and Promotes Tumor Progression Through PI3K/AKT Signaling Pathway

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s171043
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited